Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer
Qiannan Zhu,1 Jue Wang,1 Yuenian Shi,2 Xiaoming Zha,1 Shui Wang1 1The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People’s Republic of China; 2Nanjing Medical University, Nanjing, Jiangsu, 210029, People’s Republic of ChinaCorrespondence: Shui Wang; Xiaoming Zha, The Fi...
Main Authors: | Zhu Q, Wang J, Shi Y, Zha X, Wang S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-08-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/bioinformatics-prediction-and-in-vivo-verification-identify-slc7a5-as--peer-reviewed-fulltext-article-CMAR |
Similar Items
-
Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC
by: Shanshan Jiang, et al.
Published: (2023-01-01) -
Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies
by: Tonghu Liu, et al.
Published: (2023-11-01) -
The prognostic value of MKL1 in predicting breast cancer immune infiltrates and chemosensitivity
by: Yijia Hua, et al.
Published: (2022-06-01) -
SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma
by: Xin Cheng, et al.
Published: (2022-04-01) -
Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma
by: Yimin Liang, et al.
Published: (2022-10-01)